RESUMEN
PURPOSE: To find whether extracorporeal magnetic innervation (ExMi) changes the low urinary tract symptoms and sexual function in patients with chronic pelvic pain syndrome (CPPS). MATERIALS AND METHODS: ExMi treatment was performed in 51 patients, diagnosed as National Institute of Health (NIH) type III prostatitis, with each treatment session composed of 10 min at 40Hz, 2 min rest and 10 min at 50Hz. Both before and after the completion of 8 sessions of ExMi, self-administered NIH-chronic prostatitis symptom index (NIH-CPSI) and International Index of Erectile Function (IIEF) questionnaires were completed to assess the changes in the patient's symptoms. RESULTS: Following the ExMi treatment, 25 of the 40 patients experienced a 30% or greater improvement of low urinary tract symptoms. The total NIH-CPSI scores ranged from 22.4 to 15.6 (p<0.05). Each domain of the NIH-CPSI was as follows: pain, from 9.0 to 6.2; urination, from 6.7 to 4.8 and effect on the quality of life, from 6.6 to 4.5, and 11 of the 26 patients experienced a 15% or greater improvement of their sexual function. The mean total IIEF scores ranged from 44.1+/-13.5 to 51.6+/-11.3 (p<0.05). Each domain of the IIEF was as follows: erectile function, from 19.5 7.0 to 21.7+/-5.6 (p<0.05); intercourse satisfaction, from 7.4+/-2.2 to 9.5+/-2.2 (p<0.05); orgasm function, from 6.5+/-2.2 to 6.6+/-2.6 (p=0.516); sexual desire, from 6.2+/-1.9 to 6.3+/-1.6 (p=0.294) and overall satisfaction from 5.4+/-1.5 to 7.3+/-1.3 (p<0.05). CONCLUSIONS: result, ExMi was shown to reduce the lower urinary tract symptoms, and enhances the sexual function in CPPS, suggesting ExMi is effective and may help in the management of CPPS.